Identification of cellular microRNA miR-188-3p with broad-spectrum anti-influenza A virus activity
Authors:
Open Access
- 30 January 2020
- journal article
- research article
- Published by Springer Nature in Virology Journal
- Vol. 17 (1) , 1-12
Abstract
Background: Influenza A virus (IAV) continues to pose serious threats to public health. The current prophylaxis and therapeutic interventions for IAV requires frequent changes due to the continuous antigenic drift and antigenic shift of IAV. Emerging evidence indicates that the host microRNAs (miRNAs) play critical roles in intricate host-pathogen interaction networks. Cellular miRNAs may directly target virus to inhibit its infection and be developed as potential anti-virus drugs. Methods: In this study, we established a broad-spectrum anti-IAV miRNA screening method using miRanda software. The screened miRNAs were further verified by luciferase assay, viral protein expression assay and virus replication assay. Results: Five cellular miRNAs (miR-188-3p, miR-345-5p, miR-3183, miR-15-3p and miR-769-3p), targeting 99.96, 95.31, 92.9, 94.58 and 97.24% of human IAV strains recorded in NCBI, respectively, were chosen for further experimental verification. Finally, we found that miR-188-3p downregulated PB2 expression at both mRNA and protein levels by directly targeted the predicted sites on PB2 and effectively inhibited the replication of IAV (H1N1, H5N6 and H7N9) in A549 cells. Conclusions: This is the first report screening cellular miRNAs that broad-spectrum inhibiting IAV infection. These findings suggested that cellular miR-188-3p could be used for RNAi-mediated anti-IAV therapeutic strategies.Keywords
Funding Information
- National Major Research & Development Program (2016YFD0500505, 2016YFD0501001)
This publication has 53 references indexed in Scilit:
- Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genomeThe Lancet, 2013
- Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling studyThe Lancet Infectious Diseases, 2012
- Cellular microRNA let‐7c inhibits M1 protein expression of the H1N1 influenza A virus in infected human lung epithelial cellsJournal of Cellular and Molecular Medicine, 2012
- Cellular MicroRNAs Inhibit Replication of the H1N1 Influenza A Virus in Infected CellsJournal of Virology, 2010
- Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus InfectionScience, 2010
- Transforming growth factor- -regulated miR-24 promotes skeletal muscle differentiationNucleic Acids Research, 2008
- Endogenous human microRNAs that suppress breast cancer metastasisNature, 2008
- Nuclear traffic of influenza virus proteins and ribonucleoprotein complexesVirus Research, 2007
- MicroRNA function in animal developmentFEBS Letters, 2005
- Correction: Human MicroRNA TargetsPLOS Biology, 2005